Timedora
Free Online Flashcard Deck

2 Medications for Diabetes Beyond Insulin Free Online FlashCards

Study 2 Medications for Diabetes Beyond Insulin with 12 free online flashcards. Review key terms, definitions, and concepts with this interactive flashcard deck.

12 cards
01
Front

How does metformin lower blood glucose?

Back

Metformin decreases glucose production by the liver and improves insulin sensitivity.

02
Front

Why can skipping a meal be risky with glipizide?

Back

Sulfonylureas stimulate pancreatic beta cells to release insulin, so skipping or delaying a meal can raise the risk of hypoglycemia.

03
Front

What is important about meglitinide dosing and meals?

Back

Meglitinides stimulate short-acting insulin release around mealtimes. Follow the specific medicine’s instructions for a skipped meal rather than assuming the usual dose should be taken.

04
Front

How do SGLT2 inhibitors lower blood glucose?

Back

SGLT2 inhibitors reduce glucose reabsorption in the kidneys, increasing the amount of glucose excreted in urine.

05
Front

Can SGLT2 inhibitor–associated ketoacidosis occur without very high glucose?

Back

SGLT2 inhibitor–associated ketoacidosis can occur even when blood glucose is not markedly elevated. Nausea, abdominal pain, or rapid breathing during illness needs urgent medical assessment.

06
Front

What health outcomes can SGLT2 inhibitors benefit?

Back

SGLT2 inhibitors can benefit heart and kidney outcomes. For some people with type 2 diabetes and heart failure, chronic kidney disease, or cardiovascular disease, they may be recommended for these benefits.

07
Front

What are the main actions of GLP-1 receptor agonists?

Back

GLP-1 receptor agonists enhance glucose-dependent insulin release, reduce glucagon, slow gastric emptying, and increase satiety.

08
Front

What common effect may occur when starting a GLP-1–based medicine?

Back

Nausea and other gastrointestinal effects are common with GLP-1–based medicines. Gradual dose escalation is often used to help manage tolerability.

09
Front

Why are GLP-1–based medicines generally not combined with DPP-4 inhibitors?

Back

GLP-1–based medicines are generally not combined with DPP-4 inhibitors because the combination adds little glucose-lowering benefit.

10
Front

What is a typical weight and hypoglycemia profile of DPP-4 inhibitors used alone?

Back

DPP-4 inhibitors slow incretin breakdown, supporting glucose-dependent insulin release and reducing glucagon. Alone, they are usually weight-neutral and have low hypoglycemia risk.

11
Front

Why should thiazolidinediones be avoided in heart failure?

Back

Thiazolidinediones such as pioglitazone can cause fluid retention and worsen heart failure; they should be avoided in people with heart failure.

12
Front

How and when are alpha-glucosidase inhibitors used?

Back

Alpha-glucosidase inhibitors slow intestinal carbohydrate digestion and absorption, mainly reducing after-meal glucose rises. Take them with the first bite of a meal as directed.